Skip to main content
COVID-19 UPDATES > Visit J&J IM Global Website Visit JJP Website
 
Home

中国

 
  • 简体中文
  • English
 
SEARCH

 

 
  • 简体中文
  • English
 
 
 
 
 

Collaborating in more than 150 countries.
By clicking on a link below, you may enter a different part of this website, or a website outside of Janssen.com. These sections or websites are governed by their own Legal and Privacy Policies.

关闭
Global
  • Janssen Global

    English|Español
    Français|Português(BR)
    Italiano|한국어
    РУССКИЙ

Asia Pacific
  • Asia Pacific (Regional)

    English

  • Australia

    English

  • China

    中文

  • India

    English

  • Japan

    日本

  • Korea

    한국어

  • New Zealand

    English

Europe, Middle East & Africa (EMEA)
  • EMEA (Regional)

    English

  • Austria

    Deutsch

  • Belgium

    English | Français | Nederlands

  • Croatia

    HRVATSKI

  • Czech Republic

    Čeština

  • Denmark

    Dansk

  • Estonia

    English

  • Finland

    Suomi

  • France

    Français

  • Germany

    Deutsch

  • Greece

    ΕΛΛΗΝΙΚΑ

  • Hungary

    Magyar

  • Ireland

    English

  • Israel

    עברית

  • Italy

    Italiano

  • Kazakhstan

    Русский

  • Latvia

    English

  • Lithuania

    English

  • Netherlands

    Nederlands

  • Norway

    Norsk

  • Poland

    Polski

  • Portugal

    Português

  • Romania

    Română

  • Russia

    Русский

  • Slovakia

    SLOVENČINA

  • Slovenia

    Slovenščina

  • South Africa

    English

  • Spain

    Español

  • Sweden

    Svensk

  • Switzerland

    Deutsch | Français

  • Turkey

    Türkçe

  • United Kingdom

    English

Latin America
  • Argentina

    Español

  • Bolivia

    Español

  • Brazil

    Português

  • Central America and the Caribbean

    Spanish | English

  • Chile

    Español

  • Colombia

    Español

  • Mexico

    Español

  • Paraguay

    Español

  • Peru

    Español

  • Uruguay

    Español

North America
  • Canada

    English | Français

  • United States

    English

Welcome to Johnson & Johnson Innovative Medicine

About UsPrescription Products OTC Products THERAPEUTIC AREA Contact Us

Breadcrumb

  1. Home
  2. News Center
  3. Corporate News
2015/10/27
Remicade® Added to the Reimbursement List for Drugs Treating Major Illnesses in Hangzhou
Recently, Hangzhou Human Resource and Social Security Bureau released the notice of execution on the major illnesses medical insurance program that 15 drugs with definite therapeutic effects for major...
2015/09/16
A Little More Conversation, A Little More Action (MM Action) Let’s Make More efforts for patients with Multiple Myeloma
September 16, 2015, Beijing – Today marks the beginning of Xian Janssen Pharmaceutical Co., Ltd.’s (hereafter referred to as Xian Janssen) “MM Action” campaign in Beijing, a disease awareness campaign...
2015/07/15
"Love Helps Us Stand Tall for Life" Ankylosing Spondylitis Disease Awareness Summer Campaign for Youth Kicks off
(July 15, 2015, Beijing) Xian Janssen Pharmaceutical Ltd. launched the Ankylosing Spondylitis Disease Awareness Summer Campaign for Youth themed "Love Helps us Stand Tall for Life" in the summer vacat...
2015/05/22
CHINA FOOD AND DRUG ADMINISTRATION APPROVES ZYTIGA® FOR PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
[Beijing], [22 May 2015] – Xian Janssen Pharmaceutical Ltd.
2015/05/20
VELCADE® approved for insurance reimbursement in Inner Mongolia
——Patients seeking treatment for multiple myeloma can now seek reimbursement under the public medical insurance system (May 20, 2015, Hohhot) The Medical Insurance Bureau of Inner Mongolia announ...
2015/05/14
“You are not alone, love is always here” World Inflammatory Bowel Disease Day Campaign Launched in Beijing
(May 14th, 2015) Today, ahead of May 19th’s World Inflammatory Bowel Disease Day, the China Society of Inflammatory Bowel Disease (IBD) and Xian Janssen Pharmaceutical, Ltd. teamed up to launch the 20...
2015/03/12
Remicade® Added to the Reimbursement List for Drugs Treating Major Illnesses in Zhejiang Province
——Patients suffering specific autoimmune diseases now eligible for drug reimbursement
2014/12/24
“Keep Happy National Public Lecture Tour” Steers Students Away From Depression
Shanghai (December 24, 2014) – Students in higher education are at a high risk of anxiety and depression. Today, the “Keep Happy National Public Lecture Tour” delivered its 1000th lecture at Shanghai ...
2014/12/19
Qingdao government adds Remicade® and Velcade® to expanded reimbursement list
13 innovative drugs included for the first time in approved procurement list, expanding care for major illnesses  
2014/12/01
Xian Janssen Supports the 2014-2015 “Red Ribbon Health Ambassador’s Campus Tour” Campaign to Raise HIV/AIDS Awareness in China
Beijing, China, December 1, 2014 - Xian Janssen Pharmaceutical Ltd. (“Xian Janssen”) announced today that the company will participate in the 2014-2015 “Red Ribbon Health Ambassador’s Campus Tour” cam...

Pagination

  • First page « first
  • Previous page ‹‹
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Next page ››
  • Last page last »
Contact Us

Beijing Headquarters

  • Address: 14F, Tower 3, China Central Place, No.77, Jian Guo Road, Chaoyang…
I want to
No thanks

页脚

  • Privacy Policy
  • Pharmacovigilance Privacy Policy
  • Legal Notice
  • Medical Representative
  • Sitemap
  • Contact Us
×

FIND US

二维码加载失败...

Open the WeChat, click on the bottom of the "discovery", using the "sweep the" page.

FIND US:

wechat扬森全球多元化

All contents © Copyright Xian Janssen Pharmaceutical Ltd. 2015. All Rights Reserved
This site is published by Xian Janssen Pharmaceutical Ltd.
which is solely responsible for all site content.
This site is for residents of China only.
(陕)-非经营性-2022-0038
陕ICP备14002494号-1